老挝全球药房Laos Global Pharmacy
Carrying forward a five-thousand-year legacy, safeguarding modern health
沃拉西地尼是全球首个获批的IDH1/IDH2双靶点抑制剂,用于治疗IDH突变的2级胶质瘤,能显著延长无进展生存期并延缓放化疗需求。
所有称呼沃拉西地尼、Vorasidenib、LuciVora、Voranigo
Copyright 2024 @ haiouhealth.com All right reserved SEAGULL HEALTH
Order on WhatsApp